
GenScript Partners With Tamarind Bio to Speed AI Drug Discovery Validation
GenScript and Tamarind Bio have partnered to connect AI-powered molecular design with wet-lab validation, aiming to help researchers evaluate drug candidates faster.
PharmaCompany

GenScript Biotech Corporation has partnered with Tamarind Bio to enhance AI drug discovery validation by integrating AI-powered molecular design with wet-lab validation, facilitating quicker evaluation of drug candidates for researchers.
+0 in the last 30 days
1 announced
Latest tracker entry
announced4 days for validation
Built on Tamarind Bio's molecular design platform




MachineCon USA · from AIM Media House
An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.



